Cooperative Agreement 2604767
Award Date 6/15/26
Completion Date 5/31/28
Dollars Obligated $1.3M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Cambridge, MA 02139, USA
Similar Awards
- This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Amphix Bio Inc. to develop scalable manufacturing methods for a novel supramolecular polymer-based spinal implant. The project aims to enable safer, simpler, and lower-cost spinal fusion surgery by advancing this regenerative medicine technology. The key deliverables include scaling up the production of the...
- Federal Grant Award Summary On October 1, 2025, the National Science Foundation (NSF) awarded $305,000 to Bullseye Biodevices, Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) for a Small Business Technology Transfer (STTR) Phase I project focused on developing a novel biosensing device for intraoperative tumor margin detection. The award funds the design, development, and in situ validation of an electromechanical probe system integrated with robotic...
- This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...
- This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to President and Fellows of Harvard College (Harvard University) provides $550,000 in funding from August 1, 2024 to July 31, 2026 to develop a minimally-invasive, catheter-based additive manufacturing platform capable of creating customized medical implants directly inside the human body. The project aims to transform the field of medical implants by enabling on-demand fabrication of personalized 3D-printed...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award to Reselute, Inc. provides $998,921 to develop a novel implantable orthopedic medical device and procedure to reduce recovery duration and infection risks associated with severe traumatic fractures of the long bones. The project aims to advance a 3D-printed, antibiotic-releasing intramedullary nail to improve upon current standard-of-care implants that are prone to...
- This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Orthomechanica, Inc., a small minority-owned business located in Corvallis, OR. The funding supports the design, engineering, and preclinical validation of a novel implantable medical device that aims to improve functional outcomes for over 100,000 patients annually undergoing reconstructive surgery. The device integrates a...
- This National Science Foundation (NSF) Cooperative Agreement award, provided through the NSF Technology, Innovation, and Partnerships (CFDA #47.084) program, funds the development of a novel, fully implantable craniofacial distraction system by Ostiio LLC, a medical device company based in Philadelphia, PA. The $1,000,000 award aims to produce a magnetic, subcutaneous distraction device capable of gradually correcting skeletal abnormalities affecting craniomaxillofacial functions such as...
- Federal Grant Award Summary Millennial Materials & Devices Inc. received a $306,872 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded on August 1, 2025, with a completion date of July 31, 2026. The company is developing a 3D printed integrated sample preparation and chromatography platform designed to process limited-volume complex biological samples for proteomics research. The platform utilizes custom 3D printable carbon microbead...
- Federal Cooperative Agreement Summary Award Details: Illuminant Surgical Inc. received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on August 15, 2025, for the SBIR Phase II project titled "Novel Camera-Projector Device Leveraging Non-Invasive Registration and Projected Augmented Reality for Navigation in Minimally Invasive Spine Procedures." The project extends through...
- This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $274,811 to Anova Biomedical, Inc. to develop 3D printed personalized vascular grafts using novel elastomeric resins. The key objectives are to: 1) develop and characterize the novel 3D printing resin for producing personalized, elastic, and bioresorbable vascular grafts; 2) demonstrate the ability to 3D print vascular prosthetics using patient CT...